Eledon Pharmaceuticals, Inc. (ELDN): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2016-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$4.93M
Year ended 2016-12-31
2012-12-31: -$9.34M2013-12-31: -$15.50M2014-12-31: -$21.15M2015-12-31: -$41.80M2016-12-31: -$4.93M-$4.93M
2012-12-31 Free Cash Flow (USD) 2016-12-31
Period endedFree Cash FlowChange YoYSource filing
2016-12-31-$4.93Mn/c2018-04-02, From 2016-01-01
2015-12-31-$41.80Mn/m2017-03-03, From 2015-01-01
2014-12-31-$21.15Mn/m2017-03-03, From 2014-01-01
2013-12-31-$15.50Mn/m2016-03-10, From 2013-01-01
2012-12-31-$9.34Mn/a2015-03-26, From 2012-01-01